
Hello All!
Let’s get right into it so you are ahead of the game for this week, reading the stories no one else thought to look at. That’s why you pay for PTT…your own private investigators searching the world for you on a Sunday, so you can take on the world on Monday.
This week behind the wall:
(1) Three fresh S-1s worth your time: a defense-tech supplier to the primes, Australia’s leading neocloud, and a CNS pharma play.
(2) The CFTC just asked Wall Street how it should trade futures on a commodity that didn’t exist five years ago.
(3) A spirits M&A deal that makes a lot more sense sitting next to story #5.
(4) The quiet federal green light inside a contested $11.5 billion private equity takeover.
(5) A tariff standoff with a 72-hour fuse, still burning as you read this.
(6) Seven papers from NBER, the Fed, and Nature: why your credit card rate never comes down, whether kids derail the CEO track, and the first mRNA cancer vaccine to pass a late-stage trial.
Interesting IPOs:
Alzamend Neuro Inc — pharma company working on Alzheimer’s, Bipolar Disorder, Major Depressive Disorder, and PTSD.
SharonAI — Australia’s leading neocloud company.
Lyntris — a defense-tech company contracting with the larger builders for sensing and awareness capabilities.
New ETF Filings:
ETFs continue to get issued at a breakneck pace, largely in the same spaces. Linked below are the filings for the most interesting ones:
Interesting M&A Events:
Federal Register and other updates from Capitol Hill:
Proclamation 11056—Trump puts pause on Canada and other tariffs. This issue is very live, and may change by the time you read this.
Interesting papers from NBER and Fed Banks:
Crypto is coming of age. (Chicago Fed)
New scientific research papers:
Hope you all find some interesting stuff in here. Please reach out to us with any questions or requests for next week. ([email protected]).
Thanks for reading Passing the Torch Newsletter! Please share with friends, and maybe your subscription will become free!
Thanks for reading and as always, stay curious!
—J&E